Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%

CVE-2024-7400— Local privilege escalation in ESET products for Windows

EPSS 0.12% · P30
Get alerts for future matching vulnerabilitiesLog in to subscribe

I. Basic Information for CVE-2024-7400

Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
Local privilege escalation in ESET products for Windows
Source: NVD (National Vulnerability Database)
Vulnerability Description
The vulnerability potentially allowed an attacker to misuse ESET’s file operations during the removal of a detected file on the Windows operating system to delete files without having proper permissions to do so.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
CWE-1386
Source: NVD (National Vulnerability Database)
Vulnerability Title
ESET多款产品 安全漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
ESET Security Ultimate等都是斯洛伐克ESET公司的产品。ESET Security Ultimate是一个完整的安全解决方案。ESET NOD32 Antivirus是一款杀毒软件。ESET Internet Security是一款带防病毒功能的高级杀毒软件。 ESET多款产品存在安全漏洞,该漏洞源于允许攻击者在Windows操作系统移除检测到的文件时,潜在地允许攻击者滥用ESET的文件操作来删除没有权限删除的文件。以下产品受到影响:ESET NOD32 Antivirus、ESET
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)

Affected Products

II. Public POCs for CVE-2024-7400

#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC

III. Intelligence Information for CVE-2024-7400

登录查看更多情报信息。

IV. Related Vulnerabilities

V. Comments for CVE-2024-7400

No comments yet


Leave a comment